Characterization and Inhibition of SARS-Coronavirus Main Protease

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|6|4|361-376

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.6, Iss.4, 2006-02, pp. : 361-376

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibitor Design for SARS Coronavirus Main Protease Based on “Distorted Key Theory”

By  

Medicinal Chemistry, Vol. 3, Iss. 1, 2007-01 ,pp. : 1-6

Bentham Science Publishers

Access to resources Recommend Favorite

Coronavirus vaccine protects against SARS

By  

Inpharma, Vol. 1, Iss. 1434, 2004-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Bioinformatics Research on the SARS Coronavirus (SARS_CoV) in China

By  

Current Pharmaceutical Design, Vol. 12, Iss. 35, 2006-12 ,pp. : 4565-4572

Bentham Science Publishers

Access to resources Recommend Favorite

Glycyrrhizin: antiviral activity against SARS coronavirus

By  

Inpharma, Vol. 1, Iss. 1392, 2003-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Anti-SARS coronavirus agents: a patent review (2008 – present)

By Kumar Vathan   Jung Young-Sik   Liang Po-Huang  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 10, 2013-10 ,pp. : 1337-1348

Informa Healthcare

Access to resources Recommend Favorite